The effect of fleroxacin and ciprofloxacin on the pharmacokinetics of multiple dose caffeine.
Nicolau
D P
DP
Division of Infectious Diseases, Hartford Hospital, CT 06102, USA.
Nightingale
C H
CH
Tessier
P R
PR
Fu
Q
Q
Xuan
D W
DW
Esguerra
E M
EM
Quintiliani
R
R
D000328:Adult; D000890:Anti-Infective Agents / Q000494:pharmacology*; D002110:Caffeine / Q000008:administration & dosage / Q000493:pharmacokinetics*; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000493:pharmacokinetics*; D002939:Ciprofloxacin / Q000494:pharmacology*; D018592:Cross-Over Studies; D005260:Female; D016576:Fleroxacin / Q000494:pharmacology*; D006801:Humans; D008297:Male; D016037:Single-Blind Method
D000890:Anti-Infective Agents; D000697:Central Nervous System Stimulants; D002110:Caffeine; D002939:Ciprofloxacin; D016576:Fleroxacin